Skip to main content
. 2017 Aug 22;8:422. doi: 10.3389/fneur.2017.00422

Figure 2.

Figure 2

Purinergic P2X7 receptor (P2X7R) expression level by RT-PCR in unstimulated Krebs-Ringer solution (KRH) and benzoyl-ATP (BzATP)-stimulated monocytes in MS patients from the baseline to 12 months of interferon-beta (IFNb) and teriflunomide treatments. Data are expressed as mean ± SEM of fold change values (*p < 0.05; **p < 0.01; ***p < 0.001).